COVID-19 drug trial halted before it began
NCT ID NCT05137795
First seen May 20, 2026 · Last updated May 25, 2026 · Updated 2 times
Summary
This study was designed to see if an inhaled medication called ZYESAMI could help people with severe COVID-19 avoid needing a breathing machine. The trial was planned for adults with low oxygen levels or rapid breathing, but it was withdrawn before any participants enrolled. No results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSPNEA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.